Entrada Therapeutics, Inc. - TRDA

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Pharmaceutical Preparations
Latest data: 6/9/2026 10:01:39 PM
EDGAR CIK 0001689375

Buy Breakdown

Total $0

Sell Breakdown

Total $1,028,158

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
05/04/2026
10b5-1
05/04/2026
Sethuraman Natarajan
President, Research & Develop.
Officer
Sell
-25,907 @ $15.39
($398,809.77)
 216,317 (-10.70%) Direct
04/01/2026
10b5-1
04/02/2026
Wentworth Kory James
Chief Financial Officer
CFO
Sell
-2,500 @ $12.95
($32,375.00)
 119,010 (-2.06%) Direct
03/10/2026
10b5-1
03/11/2026
Dowden Nathan J
President & COO
Officer
Sell
-11,894 @ $13.05
($155,188.15)
 198,588 (-5.65%) Direct
03/10/2026
10b5-1
03/11/2026
Wentworth Kory James
Chief Financial Officer
CFO
Sell
-11,388 @ $13.02
($148,215.96)
 121,510 (-8.57%) Direct
03/09/2026
10b5-1
03/11/2026
Dowden Nathan J
President & COO
Officer
Sell
-3,116 @ $13.02
($40,582.78)
 210,482 (-1.46%) Direct
03/09/2026
10b5-1
03/11/2026
Wentworth Kory James
Chief Financial Officer
CFO
Sell
-5,089 @ $13.00
($66,162.60)
 132,898 (-3.69%) Direct
03/04/2026
10b5-1
03/06/2026
Wentworth Kory James
Chief Financial Officer
CFO
Sell
-7,988 @ $12.25
($97,892.14)
 137,987 (-5.47%) Direct
11/21/2025
10b5-1
11/24/2025
Wentworth Kory James
Chief Financial Officer
CFO
Sell
-8,910 @ $9.98
($88,931.60)
 110,026 (-7.49%) Direct